Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer

Emerging clinical evidence indicates that the combination of local administration of immunotherapy with systemic immune-checkpoint blockade targeting the PD-1/PD-L1 pathway improves response rates in select solid tumor indications; however, limited clinical experience with this approach exists in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Shingo, Reil, Katherine, Nelson, Kinsey, Proclivo, Veronica H., McGuire, Kathleen L., Giacalone, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357178/
https://www.ncbi.nlm.nih.gov/pubmed/35679299
http://dx.doi.org/10.1158/2326-6066.CIR-21-0879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357178/
https://www.ncbi.nlm.nih.gov/pubmed/35679299
http://dx.doi.org/10.1158/2326-6066.CIR-21-0879

Ejemplares similares